PPARA and cardiovascular disorder: In fact, PPARα agonists such as fenofibrate, gemfibrozil, and bezafibrate are used in the clinic to manage cardiovascular disease by dampening inflammation, reducing triglyceride levels, and increasing beneficial HDL cholesterol [10].